Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Radiofrequency Ablation × NET × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Carcinoma, Hepatocellular 1

Interventions

lanreotide 1 Sorafenib 1 Radiofrequency Ablation 1 Octreotide 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡